Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of dota-octreotide in China, also supports custom service. Welcome to wholesale bulk high quality dota-octreotide from our factory. Contact us for more details.
| Product Name | DOTA-Octreotide |
| Description | DOTA-Octreotide (CAS: 209277-09-8) is a radioligand precursor in which the DOTA macrocyclic chelator is conjugated to the N-terminus of octreotide, a synthetic somatostatin analog. Octreotide is an 8-amino acid peptide with the sequence {d-Phe}-Cys-Phe-{d-Trp}-Lys-Thr-Cys-{Threoninol}, where Cys2–Cys7 form a disulfide bond for cyclic conformation and the C-terminus is a reduced threoninol. Octreotide binds with high affinity to somatostatin receptors (SSTR, especially SSTR2), which are overexpressed on the surface of various neuroendocrine tumors (carcinoids, islet cell tumors, pheochromocytomas, etc.). DOTA conjugation enables labeling with ⁶⁸Ga (PET imaging), ⁹⁰Y/¹⁷⁷Lu (peptide receptor radionuclide therapy, PRRT), and other radionuclides for imaging diagnosis and targeted therapy of neuroendocrine tumors. Compared to native somatostatin, octreotide offers longer in vivo half-life and higher receptor selectivity. |
| Peptide Purity (HPLC, %) | ≥95% |
| Molecular formula | C₆₅H₉₂N₁₄O₁₇S₂ |
| Molecular weight (Da) | 1405.64 Da |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| DOTA-Octreotide | DOTA-octreotide; SSTR-targeting peptide; DOTATOC | Neuroendocrine tumor imaging/therapy, somatostatin receptor targeting, nuclear medicine theranostic peptide | N-terminal DOTA modified octreotide (8-mer with disulfide conformational constraint); high-affinity targeting of SSTR2; DOTA chelates ⁶⁸Ga / ¹⁷⁷Lu / ⁹⁰Y | C₆₅H₈₉N₁₃O₁₉S₂ | 1435.59 | ~1436.7 | Acetate | 8 (8-mer + DOTA, disulfide-cyclized) |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-DOC001 | White powder | Store at -20°C, sealed, dry and protected from light. Aliquot for storage. | Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. | Stable for 7 days at 4°C. Soluble in dilute acetic acid, normal saline and PBS. Disulfide bond is sensitive to strong reducing agents and high temperature; prone to cleavage and inactivation. Avoid high-concentration thiol reagents. | Stable for 2 years at -20°C, dry and protected from light. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-DOC001 | DOTA-octreotide (DOTATOC) targets SSTR2 for neuroendocrine tumor theranostics | DOTA-Octreotide (DOTATOC) is a classic somatostatin receptor-targeted theranostic peptide. The octreotide moiety binds with high affinity to somatostatin receptor SSTR2 overexpressed on neuroendocrine tumors, mediating receptor-mediated endocytosis and accumulation. The N-terminal DOTA macrocycle stably chelates ⁶⁸Ga (PET imaging), ¹⁷⁷Lu / ⁹⁰Y (radiotherapy). It is one of the gold-standard reagents for diagnosis, staging, efficacy evaluation and targeted radiotherapy of neuroendocrine tumors. | Neuroendocrine tumor theranostics, somatostatin receptor research, nuclear medicine imaging, targeted radiotherapy, peptide receptor targeting | Somatostatin receptor 2 (SSTR2); DOTA metal chelation site; receptor-mediated endocytosis |
Hot Tags: dota-octreotide, China dota-octreotide manufacturers, suppliers, factory, 651328-78-8, 997-20-6, CAS 191936 91 1, CAS 651328 78 8, drug delivery peptides, Transportan
